SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

True Nature Holding, Inc. – ‘8-K’ for 8/9/18 – ‘EX-99.3’

On:  Friday, 9/28/18, at 5:26pm ET   ·   For:  8/9/18   ·   Accession #:  1185185-18-1770   ·   File #:  0-53601

Previous ‘8-K’:  ‘8-K’ on 8/31/18 for 8/9/18   ·   Next:  ‘8-K’ on 10/22/18 for 9/28/18   ·   Latest:  ‘8-K’ on 4/26/24 for 4/17/24   ·   12 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 9/28/18  True Nature Holding, Inc.         8-K:1,2,3,5 8/09/18    6:237K                                   Federal Filings, LLC/FA

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     28K 
 2: EX-4.1      Instrument Defining the Rights of Security Holders  HTML     64K 
 3: EX-10.1     Material Contract                                   HTML     50K 
 4: EX-99.1     Miscellaneous Exhibit                               HTML     11K 
 5: EX-99.2     Miscellaneous Exhibit                               HTML     14K 
 6: EX-99.3     Miscellaneous Exhibit                               HTML     11K 


EX-99.3   —   Miscellaneous Exhibit


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:  <>  <> 

 

Exhibit 99.3

 

TRUE NATURE HOLDING INC. APPOINTS ADVERTISING AND DIGITAL WEB TECHNOLOGY EXECUTIVES TO ADVISORY BOARD

 

ATLANTA, September 26, 2018 (GLOBE NEWSWIRE) -- True Nature Holding, Inc. (OTCQB:TNTY) (the "Company" or "True Nature") announces the appointment of Mr. Jim Crone and Mr. Craig Olivas to its Advisory Board. Both are seasoned executives with experience in corporate growth. Crone will support the team as an advisor on market analysis and digital advertising strategy and Olivas will advise on technical implementation and web presence.

 

“We initiated our Advisory Board in 2016 to help us efficiently expand our subject matter expertise in core areas. These professionals provide us with valuable insights gained from their professional experience and network of contacts without the associated overhead costs of an in-house staff,” said Mr. Louis DeLuca, COO of True Nature. “The digital transformation in healthcare means we must quickly target our marketplaces and engage with both the consumer and healthcare providers simultaneously. This requires both strategic and tactical execution plans. The addition of these two experienced professionals is expected to have an immediate and positive impact on TNTY’s operations.” added Mr. DeLuca.

 

Mr. Crone, age 54, is an expert in advertising and marketing, with stints at BBDO, Ogilvy, LINTAS: New York and other specialty ad agencies, as well as in-house marketing roles at PRODIGY Services Company and an SAP Ventures company. He has implemented both digital and traditional advertising for clients including IBM, Mitsubishi Electric, Turner Entertainment, Alere Healthcare, and Maserati USA. “The shift toward “direct-to-consumer” healthcare makes it clear having a strong digital advertising plan is necessary for success,” said DeLuca. Mr. Crone attended the United States Military Academy and earned an MBA from Pace University.

 

Mr. Craig Olivas, age 57, is an entrepreneur with over 30 years of experience in the implementation of digital technology through complex web site development, including work for numerous publicly-held companies. “Craig is unique in his focus on the needs of publicly-held companies, which have specialized compliance requirements. He has implemented digital media and web presence for a wide range of clients, including consumer products, healthcare and technology. With Jim Crone providing strategy and Craig Olivas providing implementation advice, we believe we can execute a stronger and more cost-effective communications plan for our upcoming products and services,” explained Mr. DeLuca.

 

The Mission of True Nature Holding, Inc.

 

To leverage new technologies and services to improve healthcare and outcome for individuals, their families and their pets. We believe we can reduce the cost of healthcare, while improving the quality of life using Telehealth and Telemedicine Solutions.

 

We are building healthcare applications that focus on: patient engagement, care coordination, remote monitoring, data analytics, and may include Blockchain RX(TM) to provide applications for market participants in healthcare through the encryption of sensitive data as a service bureau.

 

Our approach is to develop these business opportunities as individual "threads" in response to client needs, ultimately creating an end-to-end set of solutions from the end user up to the healthcare provider or veterinary professional. Further, we expect to assist suppliers to the healthcare industry by allowing them to access unique technologies that bind them with their clients in a "top-down" distribution model.

 

 

 

 

We recognize it will take the investment of major market participants like Apple, Amazon, IBM, hospitals, healthcare networks, pharmacy and other providers for us to achieve critical mass. In consideration of this reality, we expect to work with these market makers in collaboration and in support of the ultimate user, the individual and their pets. The day of "direct-to-consumer" healthcare, including "the humanization of our pets" is upon us and we hope to be key parties to their evolution and success.

 

Statement Under the Private Securities Litigation Reform Act


As contemplated by the provisions of the Safe Harbor section of the Private Securities Litigation Reform Act of 1995, this news release contains forward-looking statements pertaining to future, anticipated, or projected plans, performances and developments, as well as other statements relating to future operations. All such forward-looking statements are necessarily only estimating or predictions of future results or events and there can be no assurance that actual results or events will not materially differ from expectations. Further information on potential factors that could affect True Nature Holding, Inc. is included in the Company's filings with the Securities and Exchange Commission. We expressly disclaim any intent or obligation to update any forward-looking statements.

 

 

Investor Contact for True Nature Holding, Inc.:

contact@truenaturepharma.com

844-383-TNTY (8689)

https://truenaturepharma.com/

SOURCE:

True Nature Holding, Inc.

Contact:

 

 

 

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed on:9/28/18
9/26/18
For Period End:8/9/188-K
 List all Filings 


12 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 7/14/23  Mitesco, Inc.                     10-K       12/31/22   75:12M                                    Federal Filings, LLC/FA
10/20/22  Mitesco, Inc.                     S-1/A                 98:16M                                    Federal Filings, LLC/FA
10/03/22  Mitesco, Inc.                     S-1/A                 89:15M                                    Federal Filings, LLC/FA
 9/12/22  Mitesco, Inc.                     S-1/A                 86:15M                                    Federal Filings, LLC/FA
 8/03/22  Mitesco, Inc.                     S-1/A                 86:12M                                    Federal Filings, LLC/FA
 6/30/22  Mitesco, Inc.                     S-1/A                 86:12M                                    Federal Filings, LLC/FA
 4/26/22  Mitesco, Inc.                     S-1/A                 72:9M                                     Federal Filings, LLC/FA
 4/05/22  Mitesco, Inc.                     10-K       12/31/21   76:8.7M                                   Federal Filings, LLC/FA
 2/10/22  Mitesco, Inc.                     S-1/A                 92:16M                                    Federal Filings, LLC/FA
11/26/21  Mitesco, Inc.                     S-1        11/24/21   90:15M                                    Federal Filings, LLC/FA
 4/27/21  Mitesco, Inc.                     S-1         4/26/21   76:9.3M                                   Federal Filings, LLC/FA
 3/25/21  Mitesco, Inc.                     10-K       12/31/20   80:9.2M                                   Federal Filings, LLC/FA
Top
Filing Submission 0001185185-18-001770   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., May 13, 11:35:44.2pm ET